Publications

Filter by Category

All Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Publish Date

Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool

Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments

Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes

July 8, 2015

Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates

Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C

January 8, 2015

Towards Host-Directed Therapies for Tuberculosis

Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm

FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease

The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification

June 26, 2015

Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research

Previous2526 27...34 Next